These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 32400191

  • 1. Subtypes of masked hypertension and target organ damage in untreated outpatients.
    Zhang DY, Cheng YB, Guo QH, Wang Y, Sheng CS, Huang QF, An DW, Li MX, Huang JF, Xu TY, Wang JG, Li Y.
    Blood Press; 2020 Oct; 29(5):299-307. PubMed ID: 32400191
    [Abstract] [Full Text] [Related]

  • 2. Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.
    Wen RW, Chen XQ, Zhu Y, Ke JT, Du Y, Wang C, Lou TQ.
    BMC Nephrol; 2020 Dec 11; 21(1):541. PubMed ID: 33308181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H, Gong WY, Zhang QZ, Zhang J, Ye ZC, Peng H, Wang C, Lou T.
    Nephrology (Carlton); 2016 Oct 11; 21(10):841-50. PubMed ID: 26566951
    [Abstract] [Full Text] [Related]

  • 5. Risk of Target Organ Damage in Children With Primary Ambulatory Hypertension: A Systematic Review and Meta-Analysis.
    Chung J, Robinson CH, Yu A, Bamhraz AA, Ewusie JE, Sanger S, Mitsnefes M, Parekh RS, Raina R, Thabane L, Dionne JM, Chanchlani R.
    Hypertension; 2023 Jun 11; 80(6):1183-1196. PubMed ID: 36802759
    [Abstract] [Full Text] [Related]

  • 6. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y, Yonemoto K, Mukai N, Nagata M, Ikeda F, Matsumura K, Kitazono T, Kiyohara Y.
    Stroke; 2013 Jun 11; 44(6):1512-7. PubMed ID: 23640825
    [Abstract] [Full Text] [Related]

  • 7. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I, Tsioufis C, Dimitriadis K, Syrseloudis D, Valenti P, Almiroudi M, Lioni L, Tousoulis D, Stefanadis C.
    Blood Press Monit; 2011 Oct 11; 16(5):218-23. PubMed ID: 21914984
    [Abstract] [Full Text] [Related]

  • 8. Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study.
    Diaz KM, Veerabhadrappa P, Brown MD, Whited MC, Dubbert PM, Hickson DA.
    Am J Hypertens; 2015 Jul 11; 28(7):900-8. PubMed ID: 25499058
    [Abstract] [Full Text] [Related]

  • 9. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.
    Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU, Schneider MP.
    Hypertension; 2018 Oct 11; 72(4):929-936. PubMed ID: 30354716
    [Abstract] [Full Text] [Related]

  • 10. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study.
    Oe Y, Shimbo D, Ishikawa J, Okajima K, Hasegawa T, Diaz KM, Muntner P, Homma S, Schwartz JE.
    Am J Hypertens; 2013 Jun 11; 26(6):808-15. PubMed ID: 23446956
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Masked hypertensives: A disguised arterial stiffness population.
    Antza C, Doundoulakis I, Stabouli S, Tziomalos K, Kotsis V.
    J Clin Hypertens (Greenwich); 2019 Oct 11; 21(10):1473-1480. PubMed ID: 31498516
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Subclinical arterial and cardiac damage in white-coat and masked hypertension.
    Wojciechowska W, Stolarz-Skrzypek K, Olszanecka A, Klima Ł, Gąsowski J, Grodzicki T, Kawecka-Jaszcz K, Czarnecka D.
    Blood Press; 2016 Aug 11; 25(4):249-56. PubMed ID: 26953075
    [Abstract] [Full Text] [Related]

  • 17. Target organ damage and masked hypertension in the general population: the Finn-Home study.
    Hänninen MR, Niiranen TJ, Puukka PJ, Kesäniemi YA, Kähönen M, Jula AM.
    J Hypertens; 2013 Jun 11; 31(6):1136-43. PubMed ID: 23466942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.